抗真菌药物管理核心推荐:真菌研究组教育与研究联盟声明
本文由真菌研究组教育与研究联盟跨学科专家小组基于文献综述制定,围绕抗真菌药物管理(AFS)提出核心推荐。AFS是抗菌药物管理(AMS)的新兴重要组成部分,但在专业知识、教育、优化利用干预、治疗药物监测及数据分析报告等方面需特殊考量。
要点
- AFS是AMS的新兴重要组成部分,需特殊考量。
- AFS特殊领域包括专业知识、教育、优化利用干预、治疗药物监测、数据分析与报告。
- 推荐基于文献综述与跨学科专家小组证据综合。
核心结论
- AFS是AMS的新兴重要组成部分,但在专业知识、教育、优化利用干预、治疗药物监测及数据分析与报告等领域需特殊考量。
研究设计与样本
- 由真菌研究组教育与研究联盟成员组成的跨学科专家小组,基于文献综述与证据综合制定推荐。
关键数值与推荐
- AFS需在专业知识、教育、优化利用干预、治疗药物监测及数据分析与报告等方面进行特殊考量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In recent years, the global public health community has increasingly recognized the importance of antimicrobial stewardship (AMS) in the fight to improve outcomes, decrease costs, and curb increases in antimicrobial resistance around the world. However, the subject of antifungal stewardship (AFS) has received less attention. While the principles of AMS guidelines likely apply to stewarding of antifungal agents, there are additional considerations unique to AFS and the complex field of fungal infections that require specific recommendations. In this article, we review the literature on AMS best practices and discuss AFS through the lens of the global core elements of AMS. We offer recommendations for best practices in AFS based on a synthesis of this evidence by an interdisciplinary expert panel of members of the Mycoses Study Group Education and Research Consortium. We also discuss research directions in this rapidly evolving field. AFS is an emerging and important component of AMS, yet requires special considerations in certain areas such as expertise, education, interventions to optimize utilization, therapeutic drug monitoring, and data analysis and reporting.
引用
- Johnson MD, Lewis RE, Dodds Ashley ES, et al. Core Recommendations for Antifungal Stewardship: A Statement of the Mycoses Study Group Education and Research Consortium. J Infect Dis. 2020. PMID: 32756879. doi:10.1093/infdis/jiaa394
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。